Comparison of ED for Different PET Tracers Based on Preclinical and Clinical Dosimetry Studies
| Tracer | Target organ | Clinical (μSv/MBq) | Preclinical (μSv/MBq) | Deviation (%) | Reference |
| (−)-18F-flubatine | Brain | 23.4 | 12.5 (mouse) | 44.0 | This study |
| 14.7 (piglet) | 34.0 | ||||
| 18F-RGD-K5 | Cancer imaging | 31.0 | 22.2 (monkey) | 28.4 | (20) |
| 18F-BMS747158 | Myocardial imaging | 19.0 | 15 (monkey) | 21.1 | (21,22) |
| 18F-FEDAA1106 | Evaluation of neuroinflammatory diseases | 36.0 | 23.5 (mouse) | 34.7 | (23) |
| 11C-choline | Oncologic | 4.4 | 2.8 (rat) | 36.0 | (24) |
| 11C-DASB | Brain | 7.0 | 6.2 (monkey) | 11.4 | (25,26) |
| 11C-telmisartan | Liver | 4.2 | 3.7 (rat) | 13.1 | (27) |